Showing results (211-220 of 241) with videos related to

Sort By:
Pageof 25
JCO Precision Oncology|August 7, 2025
Implementation of DPYD and UGT1A1 Testing in Patients With GI Cancer: A Prospective, Nonrandomized Clinical TrialSony Tuteja, Mari Angelica S Cayabyab, Glenda Hoffecker, et al.
Emerging Microbes & Infections|November 19, 2024
Evaluation of waning of IgG antibody responses after rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccines: a modelling study from the PREVAC randomized trialSimon Valayer, Marie Alexandre, Mélanie Prague, et al.
The Lancet. Global Health|February 16, 2024
Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose in young women aged 15-20 years in Kenya (KEN SHE): an immunobridging analysis of randomised controlled trialsKathy Baisley, Troy J Kemp, Nelly R Mugo, et al.
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
Multi-ancestry Genome-Wide Association Meta-Analysis Identifies Novel Loci in Atopic DermatitisMeritxell Oliva, Mrinal K Sarkar, Michael E March, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 24, 2024
Novel insights into the phenotypic spectrum and pathogenesis of Hardikar syndromeAlanna Strong, Michael E March, Christopher J Cardinale, et al.
The Lancet. Global Health|September 16, 2022
Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trialDeborah Watson-Jones, John Changalucha, Hilary Whitworth, et al.
Plos Neglected Tropical Diseases|January 30, 2026
Effect of the time of day for vaccination on the immune response to Ebola Virus Disease vaccines: A modeling study from PREVAC randomized trialAnge-Marie D Kpetigo, Marie Alexandre, Aboubacar Camara, et al.
Plos Medicine|March 2, 2011
Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysisNicola Low, Matthew F Chersich, Kurt Schmidlin, et al.
Vaccine|June 30, 2026
Effect of malaria parasitaemia on antibody responses to single-dose and two-dose HPV vaccination: results from the DoRIS dose-reduction immunogenicity trial in Tanzanian girlsHilary S Whitworth, Khalid B Beshir, Kathy J Baisley, et al.
The Lancet. Global Health|January 31, 2025
Durability of immunogenicity at 5 years after a single dose of human papillomavirus vaccine compared with two doses in Tanzanian girls aged 9-14 years: results of the long-term extension of the DoRIS randomised trialDeborah Watson-Jones, John Changalucha, Caroline Maxwell, et al.
Pageof 25